Addex Therapeutics GAAP EPS of -CHF 0.19

Aug. 18, 2022 1:39 AM ETAddex Therapeutics Ltd (ADXN), ADDXFBy: Meghavi Singh, SA News Editor
  • Addex Therapeutics press release (NASDAQ:ADXN): Q2 GAAP EPS of -CHF 0.19.
  • Cash and cash equivalents amounted to CHF 8.8M as of June 30, 2022 compared to CHF 18.1M as of June 30, 2021. 
  • CHF 4.6M equity financing in July extends cash runway into Q2 2023.

Recommended For You


To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.